ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 110 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,293,057 | -19.6% | 343,272 | +1.0% | 0.00% | 0.0% |
Q2 2023 | $2,851,559 | +5.6% | 339,876 | +25.0% | 0.00% | 0.0% |
Q1 2023 | $2,699,401 | +22.0% | 271,843 | -14.5% | 0.00% | 0.0% |
Q4 2022 | $2,212,215 | +33.4% | 317,847 | +2.4% | 0.00% | 0.0% |
Q3 2022 | $1,658,000 | +25.4% | 310,406 | -6.3% | 0.00% | – |
Q2 2022 | $1,322,000 | -10.1% | 331,357 | +0.2% | 0.00% | – |
Q1 2022 | $1,470,000 | +55.2% | 330,537 | +39.7% | 0.00% | – |
Q4 2021 | $947,000 | -58.4% | 236,640 | -8.8% | 0.00% | -100.0% |
Q3 2021 | $2,277,000 | +42.8% | 259,461 | +84.2% | 0.00% | – |
Q2 2021 | $1,595,000 | +79.8% | 140,828 | +88.6% | 0.00% | – |
Q1 2021 | $887,000 | +1674.0% | 74,676 | +929.6% | 0.00% | – |
Q4 2020 | $50,000 | +2400.0% | 7,253 | +2960.3% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 237 | -54.0% | 0.00% | – |
Q2 2020 | $2,000 | -95.1% | 515 | -96.9% | 0.00% | – |
Q1 2020 | $41,000 | -60.2% | 16,751 | -5.8% | 0.00% | – |
Q4 2019 | $103,000 | -59.6% | 17,790 | -63.3% | 0.00% | – |
Q3 2019 | $255,000 | -0.8% | 48,511 | +13.5% | 0.00% | – |
Q2 2019 | $257,000 | -32.9% | 42,736 | +0.8% | 0.00% | – |
Q1 2019 | $383,000 | +3.0% | 42,408 | -5.6% | 0.00% | – |
Q4 2018 | $372,000 | +53.1% | 44,900 | +155.9% | 0.00% | – |
Q3 2018 | $243,000 | +82.7% | 17,545 | +4.2% | 0.00% | – |
Q2 2018 | $133,000 | +22.0% | 16,838 | +15.9% | 0.00% | – |
Q1 2018 | $109,000 | +18.5% | 14,531 | +7.3% | 0.00% | – |
Q4 2017 | $92,000 | – | 13,540 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |